Perrigo (PRGO) may have attracted takeover interest from a mystery buyer. There's some speculation that CVC Capital may be evaluating a purchase of Perrigo (PRGO) to combine it with its Cooper ...

Press release: STADA and SBP Group launch strategic biosimilars partnership, including a biosimilar to Keytruda STADA and SBP Group launch strategic biosimilars partnership, including a biosimilar to ...

STADA has launched the oral spray Virustad in the German pharmacy market. Virustad is built on Enzymatica's clinically documented ColdZyme® technology. The launch follows the partnership agreement sig ...

- Despite a 4% stock surge on rumors, Perrigo’s $5B enterprise value exceeds market cap, burdened by $2.9B debt and declining revenue (-3.2% YoY in Q2). - Analysts rate Perrigo a 'Hold,' citing ...

Reports last week that German pharma group Stada was planning an initial public offering (IPO) were erroneous, as the company has just agreed to a change in private ownership. It emerged this morning ...

Johnson & Johnson’s blockbuster immunology drug Stelara is facing its first approved biosimilar in Europe, which is due to launch after the drug loses EU patent protection in July. The European ...

Sino Biopharmaceutical unit Chia Tai Tianqing Pharmaceutical Group entered into a strategic biosimilars partnership with STADA Arzneimittel, a Monday bourse filing showed. Under the contract, ...

Alvotech (the "Parent" or the "Company" or "Alvotech") is a Luxembourg public limited company (société anonyme) incorporated and existing under the laws of the Grand Duchy of Luxembourg, having its ...

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous ...

9月28日，中国生物制药（以下简称“中生”）宣布，附属公司正大天晴药业集团与德国药企STADA Arzneimittel AG（以下简称STADA）已就在研的帕博利珠单抗（K药）生物类似药TQB3570达成独家合作，授权区域覆盖欧盟、英国等市场。